JEFFREY DODD: Open Payments
NPI 1861444176 · POWHATAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,531 in 176 payments from 32 companies in 2025. Trend: 2023 $3,889 · 2024 $4,177 · 2025 $3,531
Food & beverage: $3,531
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $647 |
| AstraZeneca Pharmaceuticals LP | 16 | $428 |
| PFIZER INC. | 19 | $320 |
| Lilly USA, LLC | 11 | $320 |
| Vanda Pharmaceuticals Inc. | 9 | $210 |
| Alkermes, Inc. | 7 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $146 |
| Axsome Therapeutics, Inc. | 4 | $113 |
| Amgen Inc. | 7 | $106 |
| GlaxoSmithKline, LLC. | 6 | $96 |
Products named: VRAYLAR, NURTEC ODT, FARXIGA, FANAPT, ARISTADA, Kerendia, MOUNJARO, QULIPTA.
Industry payments across VA — which companies pay providers there.
